Amgen Enbrel (correction)
Executive Summary
Amgen did not run a statistical analysis on its clinical trial at six months (1"The Pink Sheet" May 17, 2004, p. 33). Enbrel (etanercept) received approval for psoriatic arthritis about a year before Biogen Idec Amevive (alefacept) gained approval for psoriasis...